Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Yüreğir
Clinical trial register · Turkey

Clinical Trials in Yüreğir, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Yüreğir

15 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
AstraZeneca
Phase 3
900
Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
2026-07-06
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Adana, Yüreğir, Ankara, Etlik, Sur, Edirne, Gaziantep, Şehitkamil
2025-12-22
Recruiting
AstraZeneca
Phase 3
830
Ankara, Bakırköy, Çankaya, İzmit, Küçükçekmece, Yüreğir
2025-04-10
Recruiting
Bayer
Phase 3
555
Bilkent Çankaya, Kadıköy, Istanbul, Izmir, Küçükçekmece, Sakarya, Yenimahalle, Yüreğir
2024-08-28
Recruiting
Immunocore Ltd
Phase 3
680
Yüreğir, Çankaya, Kepez, Antalya, Şehitkamil, Bahçelievler, Bornova, Cordaleo
2024-06-05
Active, closed
Regeneron Pharmaceuticals
Phase 2
51
Adana, Yüreğir, Kadıköy, Bornova, Ankara, Istanbul, Izmir
2023-04-21
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Yüreğir, Sur, İzmit, Gaziantep, Ankara, Edirne, Istanbul
2023-01-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Yüreğir, Istanbul, Izmir, İzmit, Gaziantep, Ankara, Diyarbakır, Edirne
2022-07-14
Active, closed
AstraZeneca
Phase 3
1,035
Adana, Edirne, Izmir, Şahinbey, Yüreğir
2022-03-25
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Yüreğir, Bornova, Ankara, Istanbul
2021-08-12
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Yüreğir, Ankara, Istanbul, Mersin
2020-12-21
Active, closed
Takeda
Phase 3
354
Yüreğir, Kadıköy, Bornova, Karaman, Ankara, Edirne
2020-01-10
Active, closed
pharmaand GmbH
Phase 3
1,097
Ankara, Istanbul, Manisa, Yüreğir
2018-05-14
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/y-re-ir

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Yüreğir.

How many clinical trials are recruiting in Yüreğir?

6 of the 15 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yüreğir), 15 studies
PhaseStudiesRecruitingShare
Phase 311473.3%
Phase 1/22113.3%
Phase 22113.3%

Most active sponsors

Lead sponsors with the most studies (Yüreğir)
Lead sponsorStudiesRecruiting
Regeneron Pharmaceuticals40
AstraZeneca32
Bayer11
BioNTech SE11
Genmab10
Immunocore Ltd11
Merck Sharp & Dohme LLC11
pharmaand GmbH10
Taiho Oncology, Inc.10
Takeda10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.